Comment on 'Difference between R5020 and the anti progestin RU486 in antiproliferative effects on human breast cancer cells'
- PMID: 3196889
- DOI: 10.1007/BF01805744
Comment on 'Difference between R5020 and the anti progestin RU486 in antiproliferative effects on human breast cancer cells'
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical